Direct answer
A practical Canadian framework for receiving, cold-chain assessment, storage, aliquoting and chain-of-custody records for peptide research materials.
- Stability depends on the sequence, physical form, formulation, container and exposure history.
- Recording receipt condition is more defensible than assuming every cold shipment remained within range.
- Aliquot planning should reduce transfers and freeze-thaw cycles while preserving concentration traceability.
What should happen before a peptide ships?
The sending and receiving parties should agree on material identity, quantity, physical form, expected storage and the evidence supporting the transport condition. A cold pack is not a stability study. Some lyophilized peptides can tolerate short ambient exposure, while prepared solutions may be more vulnerable to hydrolysis, oxidation, aggregation or microbial contamination.
Classify the complete shipment, including solvents, preservatives, dry ice and other components. Transport Canada dangerous-goods requirements apply when the shipment meets a regulated classification. The peptide name alone does not answer that question.
What should the receiving record capture?
Record delivery time, external condition, seal integrity, coolant state, temperature indicator data when present, vial count, lot and label agreement. Photograph damage or a mismatch before opening further. Move accepted material into controlled storage and document the storage location.
If an excursion occurred, quarantine the lot while the scientific owner assesses sequence-specific stability information. Do not convert a missing temperature record into a claim that the material is unaffected. The appropriate response may be release, additional testing or rejection, depending on risk and evidence.
How should lyophilized and prepared forms be handled?
Lyophilization reduces molecular mobility but does not eliminate water, oxygen or light-related degradation. Keep containers closed, protect from inappropriate light exposure and allow cold vials to equilibrate before opening when condensation is a concern. Record the mass basis used for any preparation.
Once a solution is prepared, buffer composition, pH, concentration and surfaces can change stability. Create aliquots sized for actual experiments. Use validated low-binding materials when adsorption is plausible, and label every aliquot with parent lot, concentration, solvent, preparation date and operator.
How many freeze-thaw cycles are acceptable?
There is no universal number. A one-cycle rule is conservative, but evidence should come from the sequence and formulation under study. Freeze concentration, ice interfaces and thaw time can alter peptides and proteins. If repeat use is unavoidable, design a small stability comparison with orthogonal readouts rather than relying on appearance.
Compare identity, purity, recovery and the functional endpoint where relevant. A vial can remain visually clear while losing material to adsorption or forming low-level related species. Record each cycle so unexplained assay drift can be investigated.
What closes the chain of custody?
The final record connects purchase order, supplier lot, certificate, receiving event, storage location, aliquot preparation and experimental file. Disposal or return should also be documented. This chain lets a Canadian laboratory defend the identity of the material that produced a result and compare data across sites or seasons.
Continue through the evidence
Methods and quality. How to Read a Peptide Certificate of Analysis, HPLC Peptide Purity: How to Read a Chromatogram Without Overclaiming, LC-MS for Peptide Identity: Molecular Mass, Charge States and Sequence Evidence and Albumin Binding and Acylated Peptides: A Research Methods Guide.
Connected peptide briefings. Peptide Lyophilization, Water Content and Storage: A Laboratory Guide, Peptide Freeze-Thaw Stability: Designing a Defensible Study, Low-Binding Tubes and Peptide Adsorption: Preventing Invisible Sample Loss, Research Peptides in Canada: A Laboratory Procurement Guide, Health Canada, Peptides and Research Use Only: What the 2026 Guidance Means, Peptide COA and SDS Review: A Canadian Procurement Checklist, Canadian Clinical Trial Rules for Peptide Investigators and Importing Research Peptides into Canada: Questions Laboratories Should Ask.
Sources and further literature
- ICH Q1A(R2): Stability testing of new drug substances and productsGeneral principles for stability study design.
- PubMed: LC-UV/HRMS analysis of stress-induced GLP-1 analogue aggregatesStudy of photolytic, thermal, freeze-thaw and shaking stress.
- Transport Canada: Transportation of dangerous goodsFederal transport requirements when a shipment is classified as dangerous goods.
North Specs separates scientific education from product claims. Review primary literature, current regulations and institutional requirements before designing laboratory work.